Marincevic-Zuniga Yanara, Dahlberg Johan, Nilsson Sara, Raine Amanda, Nystedt Sara, Lindqvist Carl Mårten, Berglund Eva C, Abrahamsson Jonas, Cavelier Lucia, Forestier Erik, Heyman Mats, Lönnerholm Gudmar, Nordlund Jessica, Syvänen Ann-Christine
Department of Medical Sciences, Molecular Medicine and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Department of Pediatrics, Institution for Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
J Hematol Oncol. 2017 Aug 14;10(1):148. doi: 10.1186/s13045-017-0515-y.
Structural chromosomal rearrangements that lead to expressed fusion genes are a hallmark of acute lymphoblastic leukemia (ALL). In this study, we performed transcriptome sequencing of 134 primary ALL patient samples to comprehensively detect fusion transcripts.
We combined fusion gene detection with genome-wide DNA methylation analysis, gene expression profiling, and targeted sequencing to determine molecular signatures of emerging ALL subtypes.
We identified 64 unique fusion events distributed among 80 individual patients, of which over 50% have not previously been reported in ALL. Although the majority of the fusion genes were found only in a single patient, we identified several recurrent fusion gene families defined by promiscuous fusion gene partners, such as ETV6, RUNX1, PAX5, and ZNF384, or recurrent fusion genes, such as DUX4-IGH. Our data show that patients harboring these fusion genes displayed characteristic genome-wide DNA methylation and gene expression signatures in addition to distinct patterns in single nucleotide variants and recurrent copy number alterations.
Our study delineates the fusion gene landscape in pediatric ALL, including both known and novel fusion genes, and highlights fusion gene families with shared molecular etiologies, which may provide additional information for prognosis and therapeutic options in the future.
导致表达融合基因的结构性染色体重排是急性淋巴细胞白血病(ALL)的一个标志。在本研究中,我们对134例原发性ALL患者样本进行了转录组测序,以全面检测融合转录本。
我们将融合基因检测与全基因组DNA甲基化分析、基因表达谱分析和靶向测序相结合,以确定新出现的ALL亚型的分子特征。
我们在80例个体患者中鉴定出64个独特的融合事件,其中超过50%此前在ALL中未曾报道过。虽然大多数融合基因仅在单个患者中发现,但我们鉴定出了几个由混杂的融合基因伙伴定义的复发性融合基因家族,如ETV6、RUNX1、PAX5和ZNF384,或复发性融合基因,如DUX4-IGH。我们的数据表明,携带这些融合基因的患者除了在单核苷酸变异和复发性拷贝数改变方面有不同模式外,还表现出特征性的全基因组DNA甲基化和基因表达特征。
我们的研究描绘了儿童ALL中的融合基因图谱,包括已知和新的融合基因,并突出了具有共同分子病因的融合基因家族,这可能为未来的预后和治疗选择提供更多信息。